Long-Term Follow-Up of the Fellow Eye in Patients Undergoing Surgery on One Eye for Treating Myopic Traction Maculopathy

Table 2

Fellow eye characteristics in patients with MTM surgery.

	Group 1 ()	Group 2 ()	Group 3 ()	Group 4 ()	value
Age, years	63.26 ± 8.29	61.40 ± 6.91	62.50 ± 6.52	66.00 ± 10.93	0.664
Sex (male/female)	8/30	7/35	2/8	1/4	0.970
Refraction, D	−10.21 ± 6.15	−13.89 ± 4.50	−14.63 ± 3.74	−14.00 ± 4.74	0.015
Axial length, mm	28.21 ± 2.78	29.53 ± 1.99	30.20 ± 1.24	30.04 ± 2.41	0.016
Follow-up, months	22.55 ± 17.54	23.12 ± 14.32	34.80 ± 20.86	34.60 ± 17.16	0.138
Poststaphyloma, number
Yes	20	34	10	4	0.004
No	18	8	0	1
Chorioretinal atrophy
Yes	7	19	9	4	<0.001
No	31	23	1	1
OCT change, number
Improved	0	4	3	0	0.005
Stable	34	28	1	2
Worse	4	10	6	3
BCVA^※
Baseline	0.10	0.40	1.0	0.9	<0.001
Final	0.20	0.45	1.0	0.9	<0.001
RS, dB (final)	10.24 ± 4.10	8.83 ± 4.53	4.87 ± 4.03	5.79 ± 6.02	0.003

Kruskal-Wallis test. Fisher’s exact test. compared with Groups 2, 3, and 4. ^※Median.
BCVA: best-corrected visual acuity. RS: retinal sensitivity.